Resmetirom
Signals from filings dated August 2026 – August 2026 · Last checked 16 Nov 2026
Supply outlook
↑ GROWINGIn the filings we track: 1 plant adding this molecule, 0 exit signals, 0 intermediate projects.
↑ Coming in1 plant+20 t/yr, where filed in tonnes
↓ Leaving0no drops or surrenders found
⇄ Own intermediates0no KSM projects found
Furthest stageEIA approvedapproval is not production
Signals
↑ NEW AT SITE
+20 t/yrAurisco Pharmaceutical Co., Ltd.
Cangshan Industrial Cluster, Tiantai, Taizhou, Zhejiang
- ✓ EIA filed
- ✓ Approval notice
- ✓ EIA approved · 27 Aug 2026
- Next: completion check
- DMF / CEP
New API line in the same project as eplerenone and finerenone. Approval No. Tai Huan Jian [2026] No. 64, 27 Aug 2026. Source: EIA approval, Taizhou Ecology and Environment Bureau
Who makes Resmetirom today: 7 listings
Current manufacturers with US DMF and CEP status, plant addresses and contacts.
| Manufacturer | Country | US DMF | CEP | Contact |
|---|---|---|---|---|
| Cipla Ltd 289 Belasis Road, Mumbai Central. Mumbai, Maharashtra 400 008 India phone: 91 22 23082891 fax: 91 22 23070013 web: www.cipla.com | India | ✓ | — | In database |
| SHANDONG CHEMINSPIRE PHARMACEUTICAL CO LTD No. 68 Changzhou Road, RiZhao Industry Park, Shandong, China | China | ✓ | — | In database |
| SICHUAN ELIXIR PHARMACEUTICAL CO LTD | — | — | In database | |
| + 4 more listings in api-fdf.com → | ||||
Three examples from the api-fdf.com database, refreshed weekly. Plant addresses and contacts are shown in the database.
Follow Resmetirom
Get an email when a new filing adds, cuts or moves this molecule to the next stage.